TransMedics Group, Inc. (TMDX): R&D Expense
$69.06M
Year ended 2025-12-31
$92.47M
Trailing 12 months to 2026-06-30
+37.1%
3-year compound annual growth
+29.7%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $69.06M | +23.4% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $55.97M | +55.2% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $36.05M | +34.5% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $26.81M | +20.2% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $22.30M | +18.4% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $18.83M | -5.2% | 2023-02-27, From 2019-12-29 |
| 2019-12-28 | $19.87M | +45.5% | 2021-03-11, From 2018-12-30 |
| 2018-12-29 | $13.66M | n/a | 2020-03-17, From 2017-12-31 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | 2025-12-31 | $69.06M | +23.4% |
| InMode Ltd. (INMD) | 2025-12-31 | $13.32M | +1.4% |
| Conmed Corp (CNMD) | 2025-12-31 | $55.88M | +2.7% |
| LivaNova PLC (LIVN) | 2025-12-31 | $185.76M | +1.8% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $32.88M | +18.4% |
| Integer Holdings Corp (ITGR) | 2025-12-31 | $49.50M | -7.3% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $21.23M | -44.7% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $7.57M | +59.3% |
| Vaso Corp (VASO) | 2025-12-31 | $728.0K | -14.5% |
Compare TMDX, INMD, CNMD, LIVN side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗